Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Change in Acquisitions & Divestments: 2023-2024

Historic Change in Acquisitions & Divestments for GeneDx Holdings (WGS) over the last 2 years, with Dec 2024 value amounting to $41.1 million.

  • GeneDx Holdings' Change in Acquisitions & Divestments fell 55.34% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.1 million, marking a year-over-year increase of 92.13%. This contributed to the annual value of $41.1 million for FY2024, which is 131.13% up from last year.
  • According to the latest figures from FY2024, GeneDx Holdings' Change in Acquisitions & Divestments is $41.1 million, which was up 131.13% from $17.8 million recorded in FY2023.
  • Over the past 5 years, GeneDx Holdings' Change in Acquisitions & Divestments peaked at $41.1 million during FY2024, and registered a low of $17.8 million during FY2023.
  • Over the past 2 years, GeneDx Holdings' median Change in Acquisitions & Divestments value was $29.4 million (recorded in 2023), while the average stood at $29.4 million.
  • Data for GeneDx Holdings' Change in Acquisitions & Divestments shows a peak YoY spiked of 131.13% (in 2024) over the last 5 years.
  • GeneDx Holdings' Change in Acquisitions & Divestments (Yearly) stood at $17.8 million in 2023, then skyrocketed by 131.13% to $41.1 million in 2024.